- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 35/18 - Erythrocytes
Patent holdings for IPC class A61K 35/18
Total number of patents in this class: 399
10-year publication summary
|
34
|
30
|
31
|
46
|
55
|
53
|
46
|
40
|
22
|
8
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Rubius Therapeutics, Inc. | 78 |
38 |
| Erytech Pharma | 75 |
25 |
| RegenLab USA LLC | 65 |
15 |
| Hemanext Inc. | 80 |
13 |
| The Regents of the University of California | 18943 |
12 |
| Biomet Manufacturing, LLC | 1067 |
12 |
| Biomet, Inc. | 136 |
7 |
| Boston Medical Center Corporation | 108 |
7 |
| ZB Manufacturing, LLC | 135 |
7 |
| Cerus Corporation | 91 |
6 |
| Erydel S.p.A. | 22 |
6 |
| Trustees of Boston University | 928 |
6 |
| Sangamo Therapeutics, Inc. | 437 |
6 |
| The General Hospital Corporation | 4517 |
5 |
| Terumo Kabushiki Kaisha | 5216 |
5 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 2912 |
5 |
| ViaCell, LLC | 6 |
5 |
| Whitehead Institute for Biomedical Research | 328 |
5 |
| Beam Therapeutics Inc. | 176 |
5 |
| Fenwal, Inc. | 626 |
4 |
| Other owners | 205 |